News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
416,960 Results
Type
Article (25422)
Company Profile (150)
Press Release (391372)
Multimedia
Podcasts (118)
Webinars (17)
Section
Business (124768)
Career Advice (1259)
Deals (22306)
Drug Delivery (114)
Drug Development (60018)
Employer Resources (96)
FDA (10065)
Job Trends (9198)
News (220684)
Policy (20351)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1029)
Accelerated approval (21)
Adcomms (26)
Allergies (96)
Alliances (32689)
ALS (104)
Alzheimer's disease (906)
Antibody-drug conjugate (ADC) (258)
Approvals (10282)
Artificial intelligence (315)
Autoimmune disease (105)
Automation (18)
Bankruptcy (201)
Best Places to Work (6737)
BIOSECURE Act (17)
Biosimilars (174)
Biotechnology (66)
Bladder cancer (102)
Brain cancer (41)
Breast cancer (405)
Cancer (3338)
Cardiovascular disease (269)
Career advice (1040)
Career pathing (29)
CAR-T (179)
CDC (27)
Cell therapy (437)
Cervical cancer (18)
Clinical research (52629)
Collaboration (1142)
Company closure (1)
Compensation (407)
Complete response letters (54)
COVID-19 (1500)
CRISPR (55)
C-suite (569)
Cystic fibrosis (100)
Data (4175)
Decentralized trials (2)
Denatured (30)
Depression (95)
Diabetes (289)
Diagnostics (2655)
Digital health (18)
Diversity (10)
Diversity, equity & inclusion (25)
Drug discovery (185)
Drug pricing (204)
Drug shortages (33)
Duchenne muscular dystrophy (156)
Earnings (51440)
Editorial (49)
Employer branding (11)
Employer resources (92)
Events (59864)
Executive appointments (653)
FDA (12049)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (3)
Frontotemporal dementia (7)
Funding (760)
Gene editing (115)
Generative AI (31)
Gene therapy (347)
GLP-1 (869)
Government (2554)
Grass and pollen (5)
Guidances (283)
Healthcare (8119)
HIV (35)
Huntington's disease (27)
IgA nephropathy (65)
Immunology and inflammation (186)
Immuno-oncology (43)
Indications (82)
Infectious disease (1668)
Inflammatory bowel disease (131)
Inflation Reduction Act (12)
Influenza (59)
Intellectual property (154)
Interviews (196)
IPO (9025)
IRA (53)
Job creations (2690)
Job search strategy (896)
JPM (56)
Kidney cancer (13)
Labor market (62)
Layoffs (394)
Leadership (29)
Legal (4659)
Liver cancer (60)
Longevity (9)
Lung cancer (529)
Lymphoma (327)
Machine learning (24)
Management (38)
Manufacturing (629)
MASH (112)
Medical device (4611)
Medtech (4626)
Mergers & acquisitions (13897)
Metabolic disorders (957)
Multiple sclerosis (121)
NASH (21)
Neurodegenerative disease (179)
Neuropsychiatric disorders (77)
Neuroscience (1723)
Neurotech (1)
NextGen: Class of 2026 (3140)
Non-profit (1377)
Now hiring (47)
Obesity (542)
Opinion (258)
Ovarian cancer (100)
Pain (160)
Pancreatic cancer (151)
Parkinson's disease (167)
Partnered (21)
Patents (313)
Patient recruitment (304)
Peanut (29)
People (37658)
Pharmaceutical (77)
Pharmacy benefit managers (33)
Phase 1 (16155)
Phase 2 (22568)
Phase 3 (18116)
Pipeline (3616)
Policy (259)
Postmarket research (1781)
Preclinical (5875)
Press Release (43)
Prostate cancer (160)
Psychedelics (33)
Radiopharmaceuticals (201)
Rare diseases (587)
Real estate (3716)
Recruiting (38)
Regulatory (16114)
Reports (26)
Research institute (1131)
Resumes & cover letters (203)
Rett syndrome (8)
RNA editing (12)
RSV (51)
Schizophrenia (125)
Series A (137)
Series B (96)
Service/supplier (8)
Sickle cell disease (71)
Special edition (22)
Spinal muscular atrophy (125)
Sponsored (22)
Startups (2251)
State (2)
Stomach cancer (17)
Supply chain (84)
Tariffs (97)
The Weekly (86)
Vaccines (579)
Venture capital (72)
Weight loss (395)
Women's health (49)
Worklife (13)
Date
Today (42)
Last 7 days (312)
Last 30 days (1250)
Last 365 days (18476)
2026 (1781)
2025 (18707)
2024 (21237)
2023 (23742)
2022 (31200)
2021 (32524)
2020 (30837)
2019 (25211)
2018 (19509)
2017 (20758)
2016 (19267)
2015 (22520)
2014 (17633)
2013 (14810)
2012 (16078)
2011 (16630)
2010 (15111)
Location
Africa (536)
Alabama (45)
Alaska (2)
Arizona (106)
Arkansas (10)
Asia (29881)
Australia (4041)
California (5922)
Canada (2048)
China (893)
Colorado (253)
Connecticut (245)
Delaware (213)
Europe (64823)
Florida (982)
Georgia (160)
Hawaii (2)
Idaho (22)
Illinois (532)
India (55)
Indiana (329)
Iowa (10)
Japan (353)
Kansas (88)
Kentucky (31)
Louisiana (11)
Maine (35)
Maryland (719)
Massachusetts (4479)
Michigan (160)
Minnesota (288)
Mississippi (3)
Missouri (51)
Montana (18)
Nebraska (17)
Nevada (49)
New Hampshire (30)
New Jersey (2194)
New Mexico (23)
New York (1657)
North Carolina (935)
North Dakota (5)
Northern California (2705)
Ohio (157)
Oklahoma (11)
Oregon (28)
Pennsylvania (1296)
Puerto Rico (19)
Rhode Island (28)
South America (803)
South Carolina (26)
South Dakota (1)
Southern California (2564)
Tennessee (75)
Texas (770)
United States (22080)
Utah (117)
Vermont (1)
Virginia (208)
Washington D.C. (62)
Washington State (469)
West Virginia (2)
Wisconsin (59)
Wyoming (1)
416,960 Results for "pdc line pharma sas".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ASH 2025 | Updated Data for Ascentage Pharma‘s Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment
December 9, 2025
·
11 min read
Press Releases
PDC*line Pharma Presents Primary Clinical Results From Phase I/II Trial on PDC*lung01 Cancer Vaccine at ESMO-IO 2024
December 12, 2024
·
5 min read
Press Releases
TMC announces three specialist service lines to accelerate drug development for biotech and pharma companies
November 11, 2025
·
1 min read
Press Releases
Ascentage Pharma Announces Global Registrational Phase III Study of Olverembatinib in First-Line Treatment of Ph+ ALL Cleared by US FDA and EMA
December 5, 2025
·
8 min read
Press Releases
Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
February 5, 2026
·
6 min read
Drug pricing
Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026
Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller biotechs continue to hang in limbo.
January 6, 2026
·
5 min read
·
Annalee Armstrong
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Press Releases
Poxel Announces the Implementation of an Equity Line With IRIS Capital as Part of the Execution of the Recovery Plan
February 3, 2026
·
12 min read
Mergers & acquisitions
At JPM26, Policy and Politics Will Loom Large for Pharma as Biotech Sees the Sun
Pharmas will need to provide their latest stance on the Most Favored Nation drug pricing plans, while biotech finally gets a break after a few tough years.
January 9, 2026
·
4 min read
·
Annalee Armstrong
Mergers & acquisitions
Five Assets Given Away by Big Pharma That Ultimately Got Bought for Billions
Drug candidates don’t usually move among Big Pharma, but these five biotechs helped facilitate such hand-offs, scooping up assets from one pharma on the cheap before being bought out for billions by another.
November 19, 2025
·
9 min read
·
Tristan Manalac
1 of 41,696
Next
